Contact
Please use this form to send email to PR contact of this press release:
Fate Therapeutics Receives FDA Orphan Drug Designation for ProTmune™ in Allogeneic Hematopoietic Cell Transplantation
TO:
Please use this form to send email to PR contact of this press release:
Fate Therapeutics Receives FDA Orphan Drug Designation for ProTmune™ in Allogeneic Hematopoietic Cell Transplantation
TO: